Cellular immunotherapy for kidney transplant

· Medeor Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cellular immunotherapy for kidney transplant, covering 2024-06-07 to 2024-06-07. Get the full timeline:

Most recent: Clinical Trial Update: Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants [Phase 3]